New hope for advanced cancer: experimental drug DM005 enters first human trials
Disease control
Recruiting now
This early-phase trial tests an experimental drug, DM005, in about 136 people with advanced solid tumors (like lung, head and neck, or other cancers) that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how wel…
Phase: PHASE1 • Sponsor: Doma Biopharmaceutical（Suzhou）Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:02 UTC